Serum IL-35 Levels Is a New Candidate Biomarker of Cancer-Related Cachexia in Stage IV Non-small Cell Lung Cancer

0
43
Investigators revealed that high serum IL-35 expression was associated with NSCLC cachexia and skeletal muscle atrophy.
[Thoracic Cancer]
Full Article